Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in Eur J Pharmacol

Retrieve available abstracts of 24 articles:
HTML format

Single Articles

    June 2024
  1. SONG S, Yuan J, Fang G, Li Y, et al
    BRD4 as a Therapeutic Target for Atrial Fibrosis and Atrial Fibrillation.
    Eur J Pharmacol. 2024 Jun 5:176714. doi: 10.1016/j.ejphar.2024.176714.
    PubMed     Abstract available

    November 2023
  2. LI F, Qian LL, Wu LD, Zhang ZY, et al
    Glucose fluctuations aggravated the late sodium current induced ventricular arrhythmias via the activation of ROS/CaMKII pathway.
    Eur J Pharmacol. 2023 Nov 6:176167. doi: 10.1016/j.ejphar.2023.176167.
    PubMed     Abstract available

  3. YI Y, Tianxin Y, Zhangchi L, Cui Z, et al
    Pinocembrin attenuates susceptibility to atrial fibrillation in rats with pulmonary arterial hypertension.
    Eur J Pharmacol. 2023;960:176169.
    PubMed     Abstract available

    October 2023
  4. DE LIMA CONCEICAO MR, Teixeira-Fonseca JL, Marques LP, Souza DS, et al
    Interaction of the antiarrhythmic drug Amiodarone with the sodium channel Na(v)1.5 depends on the extracellular pH.
    Eur J Pharmacol. 2023 Oct 17:176127. doi: 10.1016/j.ejphar.2023.176127.
    PubMed     Abstract available

    May 2023
  5. LI Q, Fang Y, Peng DW, Li LA, et al
    Sacubitril/valsartan reduces susceptibility to atrial fibrillation by improving atrial remodeling in spontaneously hypertensive rats.
    Eur J Pharmacol. 2023 May 12:175754. doi: 10.1016/j.ejphar.2023.175754.
    PubMed     Abstract available

    January 2023
  6. LIU CM, Lin FJ, Chen YC, Lin YK, et al
    Modulation of post-pacing action potential duration and contractile responses on ventricular arrhythmogenesis in chloroquine-induced long QT syndrome.
    Eur J Pharmacol. 2023;941:175493.
    PubMed     Abstract available

    October 2022
  7. GONG Y, Kong B, Shuai W, Chen T, et al
    Effect of sotagliflozin on ventricular arrhythmias in mice with myocardial infraction.
    Eur J Pharmacol. 2022;936:175357.
    PubMed     Abstract available

  8. VAN BAVEL JJA, Beekman HDM, van Weperen VYH, van der Linde HJ, et al
    IKs inhibitor JNJ303 prolongs the QT interval and perpetuates arrhythmia when combined with enhanced inotropy in the CAVB dog.
    Eur J Pharmacol. 2022;932:175218.
    PubMed     Abstract available

    August 2022
  9. SHEN S, Duan J, Hu J, Qi Y, et al
    Colchicine alleviates inflammation and improves diastolic dysfunction in heart failure rats with preserved ejection fraction.
    Eur J Pharmacol. 2022;929:175126.
    PubMed     Abstract available

    July 2022
  10. NOGAWA H, Muraki Y, Kawai T, Kuninishi Y, et al
    Pharmacological characterisation of electrocardiogram J-Tpeak interval in conscious Guinea pigs.
    Eur J Pharmacol. 2022;927:175065.
    PubMed     Abstract available

  11. HAN Y, Xiong C, Zhang LZ, Wang YD, et al
    Antagonism of N/OFQ attenuates externalization of beta1-adrenergic receptor and ventricular arrhythmias in acute myocardial ischemia rat model.
    Eur J Pharmacol. 2022;929:175139.
    PubMed     Abstract available

    June 2022
    Preventive effects of (-) epicatechin on tachycardia, cardiac hypertrophy, and nuclear factor- kappaB inflammatory signaling pathway in isoproterenol-induced myocardial infarcted rats.
    Eur J Pharmacol. 2022;924:174909.
    PubMed     Abstract available

    January 2022
  13. BALLET V, Bohme GA, Brohan E, Boukaiba R, et al
    In vitro ion channel profile and ex vivo cardiac electrophysiology properties of the R(-) and S(+) enantiomers of hydroxychloroquine.
    Eur J Pharmacol. 2022;915:174670.
    PubMed     Abstract available

    December 2021
  14. THOMET U, Amuzescu B, Knott T, Mann SA, et al
    Assessment of proarrhythmogenic risk for chloroquine and hydroxychloroquine using the CiPA concept.
    Eur J Pharmacol. 2021;913:174632.
    PubMed     Abstract available

  15. KILFOIL P, Feng SL, Bassyouni A, Lee T, et al
    Characterization of a high throughput human stem cell cardiomyocyte assay to predict drug-induced changes in clinical electrocardiogram parameters.
    Eur J Pharmacol. 2021;912:174584.
    PubMed     Abstract available

    November 2021
  16. FANG J, Kong B, Shuai W, Xiao Z, et al
    Ferroportin-mediated ferroptosis involved in new-onset atrial fibrillation with LPS-induced endotoxemia.
    Eur J Pharmacol. 2021 Nov 5:174622. doi: 10.1016/j.ejphar.2021.174622.
    PubMed     Abstract available

  17. YANG HW, Lin CY, Lin FZ, Yu PL, et al
    Phosphodiesterase-1 inhibitor modulates Ca(2+) regulation in sirtuin 1-deficient mouse cardiomyocytes.
    Eur J Pharmacol. 2021;910:174498.
    PubMed     Abstract available

  18. JIE LJ, Li YD, Zhang HQ, Mao L, et al
    Mechanisms of gefitinib-induced QT prolongation.
    Eur J Pharmacol. 2021;910:174441.
    PubMed     Abstract available

    September 2021
  19. NAFFAA MM, Al-Ewaidat OA
    Ligand modulation of KCNQ-encoded (KV7) potassium channels in the heart and nervous system.
    Eur J Pharmacol. 2021;906:174278.
    PubMed     Abstract available

  20. GERGS U, Bruckner T, Hofmann B, Neumann J, et al
    The proarrhythmic effects of hypothermia in atria isolated from 5-HT4-receptor-overexpressing mice.
    Eur J Pharmacol. 2021;906:174206.
    PubMed     Abstract available

    August 2021
  21. BELEM-FILHO IJA, Brasil TFS, Fortaleza EAT, Antunes-Rodrigues J, et al
    A functional selective effect of oxytocin secreted under restraint stress in rats.
    Eur J Pharmacol. 2021;904:174182.
    PubMed     Abstract available

    June 2021
  22. BAI S, Wang X, Wu H, Chen T, et al
    Cardioprotective effect of anisodamine against ischemia/reperfusion injury through the mitochondrial ATP-sensitive potassium channel.
    Eur J Pharmacol. 2021;901:174095.
    PubMed     Abstract available

    May 2021
  23. SAPONARA S, Fusi F, Iovinelli D, Ahmed A, et al
    Flavonoids and hERG channels: Friends or foes?
    Eur J Pharmacol. 2021;899:174030.
    PubMed     Abstract available

    April 2021
  24. SILVA EAP, Carvalho JS, Dos Santos DM, Oliveira AMS, et al
    Cardiovascular effects of farnesol and its beta-cyclodextrin complex in normotensive and hypertensive rats.
    Eur J Pharmacol. 2021 Apr 2:174060. doi: 10.1016/j.ejphar.2021.174060.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.